InvestorsHub Logo

tjguy

04/25/17 3:30 AM

#2488 RE: noreen #2487

Thanks for that information about the trial in Nigeria. That was encouraging! I didn't know either that Cytocom has already run a Ph 2 trial for Crohn's Disease. They said they would begin Ph 3 in Q4 2016, but my guess is that has not happened yet. I sent an e-mail to try and find out the status of that trial. Will report if/when I hear.